In the latest session, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $9.90 down -2.46% from its previous closing price of $10.15. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 554913 shares were traded. RLAY stock price reached its highest trading level at $10.18 during the session, while it also had its lowest trading level at $9.84.
Ratios:
For a deeper understanding of Relay Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.44 and its Current Ratio is at 25.44. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 29 when Bergstrom Donald A sold 3,178 shares for $9.64 per share. The transaction valued at 30,636 led to the insider holds 530,878 shares of the business.
Catinazzo Thomas sold 2,005 shares of RLAY for $19,328 on Jan 29. The Chief Financial Officer now owns 341,846 shares after completing the transaction at $9.64 per share. On Jan 29, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,929 shares for $9.64 each. As a result, the insider received 18,596 and left with 327,738 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1.30B and an Enterprise Value of 602.05M. For the stock, the TTM Price-to-Sale (P/S) ratio is 50.83 while its Price-to-Book (P/B) ratio in mrq is 1.68. Its current Enterprise Value per Revenue stands at 23.57 whereas that against EBITDA is -1.61.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $19.23, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 10.35, while the 200-Day Moving Average is calculated to be 10.05.
Shares Statistics:
For the past three months, RLAY has traded an average of 1.08M shares per day and 1.05M over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 91.07M. Insiders hold about 30.58% of the company’s shares, while institutions hold 71.69% stake in the company. Shares short for RLAY as of Feb 15, 2024 were 9.81M with a Short Ratio of 9.09, compared to 11.29M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.70% and a Short% of Float of 9.99%.
Earnings Estimates
There are 8 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.71 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$0.81, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.68 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.59 and -$3.33 for the fiscal current year, implying an average EPS of -$2.93. EPS for the following year is -$2.8, with 9 analysts recommending between -$2.31 and -$3.11.
